Información del producto
- (2S,4S)-4-Fluoro-1-[2-[[(1R,3S)-3-(1H-1,2,4-triazol-1-ylmethyl)cyclopentyl]amino]acetyl]-2-pyrrolidinecarbonitrile
Melogliptin is a synthetic drug that inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), which regulates the production of insulin. It has a potent inhibitory effect on DPP-IV, which is an enzyme that breaks down the incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Melogliptin has been shown to reduce blood sugar levels in patients with type 2 diabetes mellitus. The drug is also an analog of pioglitazone, a thiazolidinedione antidiabetic agent. Melogliptin binds to fatty acid receptors in cells and inhibits the activity of serine proteases, such as DPP-IV, which are involved in regulating insulin resistance.
Propiedades químicas
Consulta técnica sobre: 3D-FM103531 Melogliptin
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
